Peer-reviewedCC BYJournal of human immunity
Open-label extension study of leniolisib in activated PI3Kδ syndrome: Long-term efficacy and safety
10 affiliations
- 1Laboratory of Clinical Immunology and Microbiology, , Bethesda, MD,
- 2Department of Immunology, , Prague,
- 3Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, , Rotterdam,
- 4Pediatrics Clinic, Department of Clinical and Experimental Sciences, , Brescia,
- 5Department of Pediatrics, , Dresden,
- 6Department of Immunology, , Moscow,
- 7Department of Pediatric Hematology and Oncology, , Palermo,
- 8, Minsk,
- 9, Bethesda, MD,
- 10, Warren, NJ,
Related
- Effectiveness of leniolisib in reducing infections among patients with activated phosphoinositide 3-kinase δ syndrome (APDS).
- Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del -gating and F508del -residual function genotypes: results from an open-label extension study
- Post-slaughter poultry meat preservation for sustainable food systems: Mechanisms, microbial safety, shelf-life extension, and emerging preservation strategies
- Heterozygous Mutations in MAP3K7 , Encoding TGF-β-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome
- Characterizing hypertension in activated PI3K delta syndrome: Findings from Epic Cosmos.
BibTeX
@article{rao2026openlabel,
title = {{Open-label extension study of leniolisib in activated PI3Kδ syndrome: Long-term efficacy and safety}},
author = {V. Koneti Rao and Anna Šedivá and Virgil A.S.H. Dalm and Alessandro Plebani and Catharina Schuetz and Anna Shcherbina and Antonio Trizzino and Yulia Zharankova and Alanvin Orpia and Elaine Kulm and Julia Körholz and Vassilios Lougaris and Yulia Rodina and Jason Bradt and Anurag Relan and Gulbu Uzel},
journal = {Journal of human immunity},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13664708},
note = {CC BY},
}
RIS
TY - JOUR
TI - Open-label extension study of leniolisib in activated PI3Kδ syndrome: Long-term efficacy and safety
AU - V. Koneti Rao
AU - Anna Šedivá
AU - Virgil A.S.H. Dalm
AU - Alessandro Plebani
AU - Catharina Schuetz
AU - Anna Shcherbina
AU - Antonio Trizzino
AU - Yulia Zharankova
AU - Alanvin Orpia
AU - Elaine Kulm
AU - Julia Körholz
AU - Vassilios Lougaris
AU - Yulia Rodina
AU - Jason Bradt
AU - Anurag Relan
AU - Gulbu Uzel
PY - 2026
DA - 2026/10/14
JO - Journal of human immunity
UR - https://europepmc.org/article/PMC/PMC13664708
SN - 3065-8993
ER -